Referenser

  1. Drenth-van Maanen AC, Wilting I, Jansen PAF. Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol. 2020;86(10):1921-30.

  2. Wehling M. Age-Associated General Pharmacological Aspects. In: Wehling M, editor. Drug Therapy for the Elderly: Springer-Verlag; 2013. p. 21-34.

  3. Dahlen E, Bjorkhem-Bergman L. Comparison of Creatinine and Cystatin C to Estimate Renal Function in Geriatric and Frail Patients. Life (Basel). 2022;12(6).

  4. SBU. Skattning av njurfunktion. En systematisk litteraturöversikt. Stockholm: Statens beredning för medicinsk utvärdering (SBU); 2012.

  5. Bishara D. Managing drugs with anticholinergic activity. Drug Ther Bull. 2023;61(9):135-9.

  6. Hshieh TT, Inouye SK, Oh ES. Delirium in the Elderly. Clin Geriatr Med. 2020;36(2):183-99.

  7. Wilson JE, Mart MF, Cunningham C, Shehabi Y, Girard TD, MacLullich AMJ, et al. Delirium. Nat Rev Dis Primers. 2020;6(1):90.

  8. Guirguis-Blake JM, Michael YL, Perdue LA, Coppola EL, Beil TL. Interventions to Prevent Falls in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018;319(16):1705-16.

  9. By the American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society 2023 updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-81.

  10. Dani M, Dirksen A, Taraborrelli P, Panagopolous D, Torocastro M, Sutton R, Lim PB. Orthostatic hypotension in older people: considerations, diagnosis and management. Clin Med (Lond). 2021;21(3):e275-e82.

  11. Fancello V, Hatzopoulos S, Santopietro G, Fancello G, Palma S, Skarzynski PH, et al. Vertigo in the Elderly: A Systematic Literature Review. J Clin Med. 2023;12(6).

  12. Ito K, Izumi N, Funayama S, Nohno K, Katsura K, Kaneko N, Inoue M. Characteristics of medication-induced xerostomia and effect of treatment. PLoS One. 2023;18(1):e0280224.

  13. Emmanuel A, Mattace-Raso F, Neri MC, Petersen KU, Rey E, Rogers J. Constipation in older people: A consensus statement. Int J Clin Pract. 2017;71(1).

  14. Lindberg G, Hamid SS, Malfertheiner P, Thomsen OO, Fernandez LB, Garisch J, et al. World Gastroenterology Organisation global guideline: Constipation--a global perspective. J Clin Gastroenterol. 2011;45(6):483-7.

  15. Kuzuya M. Effect of drugs on nutritional status and drug-nutrition interactions in older patients. Geriatr Gerontol Int. 2023;23(7):465-77.

  16. Dent E, Wright ORL, Woo J, Hoogendijk EO. Malnutrition in older adults. Lancet. 2023;401(10380):951-66.

  17. Abdel-Kader K, Palevsky PM. Acute kidney injury in the elderly. Clin Geriatr Med. 2009;25(3):331-58.

  18. Sinigoj P, Vene N, Kosmelj K, Mavri A. Risk of major bleeding in elderly patients with atrial fibrillation on direct oral anticoagulants: real world experience. Int J Clin Pharm. 2020;42(2):445-52.

  19. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.

  20. Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol. 2017;73(6):759-70.

  21. Flaxer JM, Heyer A, Francois D. Evidenced-Based Review and Evaluation of Clinical Significance: Nonpharmacological and Pharmacological Treatment of Insomnia in the Elderly. Am J Geriatr Psychiatry. 2021;29(6):585-603.

  22. Chen Z, Liu Z, Zeng L, Huang L, Zhang L. Research on prescribing cascades: a scoping review. Front Pharmacol. 2023;14:1147921.

  23. Sjoberg C, Ohlsson H, Wallerstedt SM. Association between multi-dose drug dispensing and drug treatment changes. Eur J Clin Pharmacol. 2012;68(7):1095-101.

  24. Sjoberg C, Edward C, Fastbom J, Johnell K, Landahl S, Narbro K, Wallerstedt SM. Association between multi-dose drug dispensing and quality of drug treatment--a register-based study. PLoS One. 2011;6(10):e26574.

  25. Wallerstedt SM, Fastbom J, Johnell K, Sjoberg C, Landahl S, Sundstrom A. Drug treatment in older people before and after the transition to a multi-dose drug dispensing system--a longitudinal analysis. PLoS One. 2013;8(6):e67088.

  26. Cole JA, Goncalves-Bradley DC, Alqahtani M, Barry HE, Cadogan C, Rankin A, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2023;10(10):CD008165.

  27. Wu J, Zhang H, Shao J, Chen D, Xue E, Huang S, et al. Healthcare for Older Adults with Multimorbidity: A Scoping Review of Reviews. Clin Interv Aging. 2023;18:1723-35.

  28. Zagt AC, Bos N, Bakker M, de Boer D, Friele RD, de Jong JD. A scoping review into the explanations for differences in the degrees of shared decision making experienced by patients. Patient Educ Couns. 2023;118:108030.

  29. SFS. Patientlagen, SFS 2014:821. Socialdepartementet; 2014.

  30. Regionala Cancercentrum i Samverkan. Nationellt vårdprogram Palliativ vård2023 2024-06-09]. Available from: https://kunskapsbanken.cancercentrum.se/globalassets/vara-uppdrag/rehabilitering-palliativ-vard/vardprogram/nationellt-vardprogram-palliativ-vard.pdf

  31. Ho KM, Morgan DJ, Johnstone M, Edibam C. Biological age is superior to chronological age in predicting hospital mortality of the critically ill. Intern Emerg Med. 2023;18(7):2019-28

  32. Abbasi M, Rolfson D, Khera AS, Dabravolskaj J, Dent E, Xia L. Identification and management of frailty in the primary care setting. CMAJ. 2018;190(38):E1134-E40.

  33. Schlegl E, Ducournau P, Ruof J. Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making. Pharmaceut Med. 2017;31(4):213-6.

  34. Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874-2071.

  35. Kok RM, Reynolds CF, 3rd. Management of Depression in Older Adults: A Review. JAMA. 2017;317(20):2114-22.

  36. Kechichian A, Lafrance S, Matifat E, Dube F, Lussier D, Benhaim P, et al. Multimodal Interventions Including Rehabilitation Exercise for Older Adults With Chronic Musculoskeletal Pain: A Systematic Review and Meta-analyses of Randomized Controlled Trials. J Geriatr Phys Ther. 2022;45(1):34-49.

  37. Garrard JW, Cox NJ, Dodds RM, Roberts HC, Sayer AA. Comprehensive geriatric assessment in primary care: a systematic review. Aging Clin Exp Res. 2020;32(2):197-205.

  38. Eamer G, Saravana-Bawan B, van der Westhuizen B, Chambers T, Ohinmaa A, Khadaroo RG. Economic evaluations of comprehensive geriatric assessment in surgical patients: a systematic review. J Surg Res. 2017;218:9-17.

  39. Roller-Wirnsberger R, Thurner B, Pucher C, Lindner S, Wirnsberger GH. The clinical and therapeutic challenge of treating older patients in clinical practice. Br J Clin Pharmacol. 2020;86(10):1904-11.

  40. Monette PJ, Schwartz AW. Optimizing Medications with the Geriatrics 5Ms: An Age-Friendly Approach. Drugs Aging. 2023;40(5):391-6.

  41. Lundgren C. FAS UT 2024: Att utvärdera, ifrågasätta och skonsamt avsluta läkemedelsbehandling. 4th ed: Studentlitteratur; 2024.

  42. Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781-7.

  43. O'Mahony D. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2020;13(1):15-22.

  44. Socialstyrelsen. Indikatorer för god läkemedelsterapi hos äldre. www.Socialstyrelsen.se: Socialstyrelsen; 2017.

  45. Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer's disease: Targeting the Cholinergic System. Curr Neuropharmacol. 2016;14(1):101-15.

  46. Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59(8):1477-83.

  47. Rube T, Ecorcheville A, Londos E, Modig S, Johansson P. Development of the Swedish anticholinergic burden scale (Swe-ABS). BMC Geriatr. 2023;23(1):518.

  48. Roy-Byrne PP. The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety. J Clin Psychiatry. 2005;66 Suppl 2:14-20.

  49. Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, Brophy JM. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ. 2017;357:j1909.

  50. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020;180:114147.

  51. Nash DM, Markle-Reid M, Brimble KS, McArthur E, Roshanov PS, Fink JC, et al. Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study. Nephrol Dial Transplant. 2019;34(7):1145-54.

  52. Modig S, Elmstahl S. Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population. Int J Clin Pharm. 2018;40(4):870-7.

  53. Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 2015;11:1061-75.

  54. Hodkinson A, Tyler N, Ashcroft DM, Keers RN, Khan K, Phipps D, et al. Preventable medication harm across health care settings: a systematic review and meta-analysis. BMC Med. 2020;18(1):313.

  55. Socialstyrelsens föreskrifter och allmänna råd om ordination och hantering av läkemedel, (2017).

  56. Wickman K, Dobszai A, Modig S, Bolmsjo BB, Caleres G, Lenander C. Pharmacist-led medication reviews in primary healthcare for adult community-dwelling patients - a descriptive study charting a new target group. BMC Prim Care. 2022;23(1):237.

  57. Milos V, Rekman E, Bondesson A, Eriksson T, Jakobsson U, Westerlund T, Midlov P. Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study. Drugs Aging. 2013;30(4):235-46.

  58. Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E, Eriksson T. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67(7):741-52.

  59. McDonagh STJ, Mejzner N, Clark CE. Prevalence of postural hypotension in primary, community and institutional care: a systematic review and meta-analysis. BMC Fam Pract. 2021;22(1):1.

  60. Bjork J, Back SE, Ebert N, Evans M, Grubb A, Hansson M, et al. GFR estimation based on standardized creatinine and cystatin C: a European multicenter analysis in older adults. Clin Chem Lab Med. 2018;56(3):422-35.

  61. Modig S, Kristensson J, Troein M, Brorsson A, Midlov P. Frail elderly patients' experiences of information on medication. A qualitative study. BMC Geriatr. 2012;12:46.

  62. Gransjon Craftman A, Grape C, Ringnell K, Westerbotn M. Registered nurses' experience of delegating the administration of medicine to unlicensed personnel in residential care homes. J Clin Nurs. 2016;25(21-22):3189-98.

  63. Caleres G, Modig S, Midlov P, Chalmers J, Bondesson A. Medication Discrepancies in Discharge Summaries and Associated Risk Factors for Elderly Patients with Many Drugs. Drugs Real World Outcomes. 2020;7(1):53-62.

  64. Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831-41.

  65. Midlov P, Bergkvist A, Bondesson A, Eriksson T, Hoglund P. Medication errors when transferring elderly patients between primary health care and hospital care. Pharm World Sci. 2005;27(2):116-20.

  66. Midlov P, Holmdahl L, Eriksson T, Bergkvist A, Ljungberg B, Widner H, et al. Medication report reduces number of medication errors when elderly patients are discharged from hospital. Pharm World Sci. 2008;30(1):92-8.

  67. Bergkvist A, Midlov P, Hoglund P, Larsson L, Bondesson A, Eriksson T. Improved quality in the hospital discharge summary reduces medication errors--LIMM: Landskrona Integrated Medicines Management. Eur J Clin Pharmacol. 2009;65(10):1037-46.

  68. Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2):e010003.

  69. Ooi CE, Rofe O, Vienet M, Elliott RA. Improving communication of medication changes using a pharmacist-prepared discharge medication management summary. Int J Clin Pharm. 2017;39(2):394-402.

  70. Kempen TGH, Kalvemark A, Sawires M, Stewart D, Gillespie U. Facilitators and barriers for performing comprehensive medication reviews and follow-up by multiprofessional teams in older hospitalised patients. Eur J Clin Pharmacol. 2020;76(6):775-84.

Föregående sida
För vidare läsning

Nästa sida
Tillbaka till kapitlets första sida